Endo Pharmaceuticals Holdings Inc. (NASDAQ:ENDP) announced on recently that it will present at the Oppenheimer and Company 21st Annual Healthcare Conference on Tuesday, November 2, 2010, at 2:10 p.m. EDT. Blaine Davis, vice president, corporate affairs at Endo, will review the company's products and development programs.
There will be a live webcast and it can be accessed from Endo's website at www.endo.com under the investors section.
Endo Pharmaceuticals is a U.S.-based, specialty healthcare solutions company, focused on high-value branded products and specialty generics. Endo is redefining its position in the healthcare marketplace by anticipating and embracing the evolution of health decisions based on the need for high-quality and cost-effective care.
GreenHouse Holdings, Inc. (OTCQB:GRHU), a San Diego, California based integrated energy solutions provider and developer of eco-friendly infrastructure, recently announced that PepsiCo(R) will partner with GreenHouse to utilize Southern California Edison's (SCE) Automated Demand Response (Auto-DR) program at its Buena Park bottling plant. GreenHouse is a qualified service provider of SCE's Auto-DR program, providing site assessment, feasibility studies, project development, engineering, installation of enabling technologies and complete processing of all incentives.
Pepsi & GreenHouse Project
The Auto-DR program offers significant financial incentives and technical support to SCE customers with automated load control systems that participate in demand response events. Auto-DR uses control systems to automatically achieve specified energy demand reductions (kW and duration) during periods of peak energy demand.
"Auto-DR is a perfect complement to Greenhouse's vision to help our clients reduce energy consumption by deploying state-of-the-art technology," says Rob Davis, Vice President of GreenHouse Holdings, Inc. "We are truly honored to be selected to partner with Pepsi and we are looking forward to the Auto-DR projects as the first of many opportunities to be included in Pepsi's corporate sustainability initiatives. This project goes to the heart of Greenhouse's mission to deliver green solutions that reduce energy consumption with a positive return on investment."
PepsiCo is a recognized leader in the beverage industry for their efforts in sustainability and energy efficiency by consistently operating their plants in the most energy-conscious manner possible.
Multiple Contract Awards
Also announced was the signing of multiple contract awards for its Life Protection (LPI) Governmental Services Division, totaling $6 million. The recently acquired LPI subsidiary provides innovative training, support, design and construction of facilities and services to meet the needs of the U. S. Government, military, and law enforcement agencies.
The governmental contracting entities include the U.S. Marine Corps School of Dynamic Entry in Quantico, VA and the U.S. Army Schofield Barracks Range Support in Honolulu, HI. The combined value of these contracts totals $1.5 million and includes GreenHouse's brand of Rapidly Assembled Portable Structures, (RAPS).
In addition, to the governmental contracts, GreenHouse has signed contracts totaling $4.5 million for commercial projects, including a design-build contract for services ranging from project management and land planning to eco-friendly building products and services. GreenHouse expects the majority of the contracted work to be completed by year end 2010.
GreenHouse Holdings, Inc. is a San Diego, California based integrator of some of the world's most innovative environmental, public safety, infrastructure technologies. GreenHouse provides systems that are financially sound and sustainable to residential, commercial, industrial and government markets around the globe. GreenHouse provides energy-efficiency products, energy management systems, eco-friendly infrastructure, scalable waste-to-fuel bio-fuel and closed loop systems, as well as other proprietary technologies and products that are utilized to provide a greener and safer future for millions of people.
GreenHouse Holdings Home Page
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) announced the initiation of a Phase 2a clinical trial that will evaluate multiple combinations of VX-770 and VX-809, investigational oral cystic fibrosis transmembrane conductance regulator (CFTR) modulators for the treatment of cystic fibrosis (CF).
The trial is designed to evaluate the safety and tolerability of VX-809 dosed alone for 14 days followed by dosing of VX-809 in combination with VX-770 for 7 days. The trial will also assess the effect of VX-809 alone and in combination with VX-770 on CFTR function, as measured by sweat chloride.
The three-part trial is designed to enroll up to a total of 160 people with two copies of the F508delCFTR mutation, the most common mutation in the CFTR gene.
Vertex Pharmaceuticals Incorporated engages in the discovery, development, and commercialization of small molecule drugs for the treatment of serious diseases worldwide.
MusclePharm(R) Corporation (OTC:MSLP), one of the fastest growing nutritional supplement companies in the United States with a proprietary formulation used in its portfolio of performance products, recently announced UFC star Jake Shields will be wearing MusclePharm apparel at the UFC 121 co-main event, which takes place on October 23 from the Honda Center in Anaheim, California.
UFC 121 Matches draw an estimated 850,000 pay per view buys and is watched by an estimated 10 million viewers.
UFC has been a tremendous partner for our company, and the exposure we will receive Saturday night addresses the perfect demographic for our brand. We are very excited to have one of our MMA athletes featured as the co-main event, commented Cory Gregory, MusclePharm's President. This branding opportunity with UFC will further increase MusclePharm's brand awareness and expand MusclePharm's supplement and apparel market penetration.
Headquartered in Denver, Colorado, MusclePharm is a rapidly expanding healthy life-style company that developments and manufacturers a full line of NSF and scientifically approved, nutritional supplements that are 100% free of any banned substances. Based on years of research, MusclePharm products are created through an advanced six-stage research protocol involving the expertise of top nutritional scientists and field tested by more than 100 elite professional athletes from various sports including the NFL, MMA, and MLB.
MSLP's proprietary and award winning products address all categories of an active lifestyle including muscle building, weight loss, and maintaining general fitness through a daily nutritional supplement regimen. MusclePharm is sold in over 120 countries and available in over 5,000 U.S. retail outlets that include GNC, and Vitamin Shoppe, as well as over 100 online stores, including bodybuilding.com, Amazon and Vitacost.com.
Apollo Group Inc. (NASDAQ:APOL) and University of Phoenix announced recently the launch of PhoenixConnect, a private, academically-focused social network providing students, alumni and faculty tools for greater collaboration, discussion and learning support. The online network will initially be available to the university's School of Business students and faculty.
Apollo Group, Inc., together with its subsidiaries, provides various educational programs and services at the undergraduate, graduate, and doctoral levels.
The company offers associate's, bachelor's, master's, and doctoral degree programs in arts and sciences, business and management, criminal justice and security, education, human services, health care, psychology, technology, and nursing through its campus locations and learning centers in 39 states and the District of Columbia, and Puerto Rico, as well as through online educational delivery system.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DoubleInStocks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. (Read more at: http://doubleinstocks.com/disclaimer) Release of Liability: Through use of this website viewing or using, you agree to hold DoubleInStocks.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings, Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received ten thousand dollars in cash and anticipates another ten thousand dollars in cash from the company for 60 days of advertisement services for Green House Holdings, Inc. (OTCQB: GRHU). In addition to the cash, Crown Equity Holdings Inc. (CRWE.OB) also anticipates receiving 20,000 shares of 144 restricted stocks from a third party.
Sign Up for our FREE Daily Stock Newsletter